VIDEOTAPE TO ENHANCE HIV COUNSELING & TESTING FOR WOMEN

艾滋病毒咨询和检测(“HIV C&T”)一直是美国 预防努力，但其在降低妇女风险方面的有效性 是有限的。 第二阶段SBIR的目标是： 1.制作一种创新的干预措施，与HIV C&T一起使用 为了减少艾滋病毒通过异性传播给妇女--具体地说， 接受艾滋病毒C&T的妇女和她们的男性观看录像带 合伙人；以及 2.严格评估录像带的减量效果 不受保护的性行为和增加伴侣测试。 这段视频是第一阶段研究的产品。它寻求加强艾滋病毒 预防措施：(1)提高妇女对基本艾滋病毒的认识 咨询信息；(2)将咨询的范围扩大到妇女 性伴侣，以及(3)帮助夫妇交流艾滋病毒风险和 预防。 干预措施将在一年内接受严格的实验评估 随机试验。这款SBIR的最终产品将是一种创新的、 彻底扎实、经过严格评估、经济实惠且具有商业价值 可行的视频干预措施，以减少艾滋病毒的异性传播到 女人。 建议的商业应用： 建议的视频将对艾滋病毒咨询和检测非常有用 网站，包括性病诊所和医院，以及私人医生， 以及艾滋病教育和外展计划。彻底搜索相关的 数据库显示当前没有可用于HIV C&T；的视频， 这种产品的商业潜力很大。米勒-芬威治公司 营销旨在帮助医疗保健专业人员 有效地向患者传达健康信息，是非常重要的 对这个项目感兴趣，并认为它从一个 营销立场。

HIV counseling and testing ("HIV C&T") has been a cornerstone of U.S. prevention efforts, yet its effectiveness in reducing risk for women has been limited. The aims of this Phase II SBIR are: 1. To produce an innovate intervention for use in conjunction with HIV C&T to reduce heterosexual transmission of HIV to women-specifically, a videotape to be viewed by women who receive HIV C&T and their male partners; and 2. To rigorously evaluate the effectiveness of the videotape in reducing unprotected intercourse and increasing partner testing. The video is the product of Phase I research. It seeks to enhance HIV prevention by: (1) improving women's understanding of essential HIV counseling messages; (2) expanding the reach of counseling to the women's sexual partners, and (3) helping couple communicate about HIV risk and prevention. The intervention will undergo rigorous experimental evaluation in a randomized trial. The end product of this SBIR will be an innovative, thoroughly grounded, rigorously evaluated, cost-effective and commercially viable video intervention to reduce heterosexual transmission of HIV to women. Proposed commercial applications: The proposed video will be extremely useful to HIV counseling and Testing sites, including STD clinics and hospitals, as well as private physicians, and AIDS education and outreach programs. A thorough search of relevant databases shows no videos currently available for use with HIV C&T; thus, the commercial potential of this product is strong. Miller-Fenwich, Inc., markets programs designed to assist health care professionals in effectively communicating health information to patients, is very interested in this project and considers it extremely viable from a marketing standpoint.